Related Articles
T‑box 2 expression is a useful indicator of the response to neoadjuvant chemotherapy for patients with locally advanced uterine cervical squamous cell carcinoma
XPA expression is a predictive marker of the effectiveness of neoadjuvant chemotherapy for locally advanced uterine cervical cancer
PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer
Significance of calreticulin as a prognostic factor in endometrial cancer
Predictive value of phosphorylated mammalian target of rapamycin for disease‑free survival in breast cancer patients receiving neoadjuvant chemotherapy